4//SEC Filing
KENNEDY KOLLEEN T 4
Accession 0001127602-21-013914
CIK 0000203527other
Filed
Apr 15, 8:00 PM ET
Accepted
Apr 16, 7:52 PM ET
Size
24.8 KB
Accession
0001127602-21-013914
Insider Transaction Report
Form 4
KENNEDY KOLLEEN T
SVP and Pres. Oncology Sys.
Transactions
- Disposition to Issuer
Performance Shares
2021-04-15−8,859→ 0 total→ Common Stock (8,859 underlying) - Disposition to Issuer
Non Qualified Stock Option (Right to Buy)
2021-04-15$146.91/sh−14,122$2,074,663→ 0 totalExercise: $30.59Exp: 2027-02-13→ Common Stock (14,122 underlying) - Disposition to Issuer
Performance Shares
2021-04-15−10,777→ 0 total→ Common Stock (10,777 underlying) - Disposition to Issuer
Restricted Stock Units
2021-04-15−12,103→ 0 total→ Common Stock (12,103 underlying) - Disposition to Issuer
Non Qualified Stock Option (Right to Buy)
2021-04-15$131.77/sh−6,002$790,884→ 0 totalExercise: $45.73Exp: 2026-02-14→ Common Stock (6,002 underlying) - Disposition to Issuer
Restricted Stock Units
2021-04-15−1,906→ 0 total→ Common Stock (1,906 underlying) - Disposition to Issuer
Common Stock
2021-04-15−29,249→ 0 total - Disposition to Issuer
Non Qualified Stock Option (Right to Buy)
2021-04-15$112.82/sh−1,630$183,897→ 0 totalExercise: $64.68Exp: 2025-02-08→ Common Stock (1,630 underlying) - Disposition to Issuer
Restricted Stock Units
2021-04-15−1,063→ 0 total→ Common Stock (1,063 underlying)
Footnotes (12)
- [F1]Amount of securities beneficially owned at end of reporting period reflect a reduction of 7 shares as a result of a tax correction for the February 16, 2021 RSU vesting.
- [F10]Each performance stock unit represents a contingent right to receive one share of VAR common stock.
- [F11]Pursuant to the Merger Agreement, these performance stock units, which were granted November 21, 2019, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
- [F12]Pursuant to the Merger Agreement, these performance stock units, which were granted November 15, 2018, were cancelled in exchange for a cash payment of $177.50 per share of underlying common stock and applicable performance conditions were deemed to be achieved at the target performance level.
- [F2]Disposed of pursuant to merger agreement (the "Merger Agreement") between issuer and Siemens Healthineers I GmbH and certain other parties in exchange for a cash payment of $177.50 per share of common stock.
- [F3]Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/8/2019, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock.
- [F4]Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/14/2020, and the remaining shares in 24 equal installments over the 24 months following, were canceled in exchange for a cash award representing the difference between $177.50 and the exercise price of the option of the underlying common stock.
- [F5]Pursuant to the Merger Agreement, these options, which provided for vesting of one third on 2/13/2021, and the remaining shares in 24 equal installments over the 24 months following, were cancelled in exchange for a cash payment representing the difference between $177.50 and the exercise price of each share of underlying common stock.
- [F6]Each restricted stock unit represents a contingent right to receive one share of VAR common stock.
- [F7]Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 14, 2020, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
- [F8]Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning November 15, 2021, were cancelled in exchange for a cash award equal to $177.50 per unvested share of underlying common stock that will vest and pay out according to the same schedule.
- [F9]Pursuant to the Merger Agreement, these restricted stock units, which provided for vesting in three equal annual installments beginning February 15, 2021, were cancelled in exchange for a cash payment of $177.50 per unvested share of underlying common stock.
Documents
Issuer
VARIAN MEDICAL SYSTEMS INC
CIK 0000203527
Entity typeother
Related Parties
1- filerCIK 0001531738
Filing Metadata
- Form type
- 4
- Filed
- Apr 15, 8:00 PM ET
- Accepted
- Apr 16, 7:52 PM ET
- Size
- 24.8 KB